MNTA - Momenta Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.94. This is a potential upside of $6.94 (0%) from yesterday's end of day stock price of $0.

Momenta Pharmaceuticals's activity chart (see below) currently has 97 price targets and 61 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.11% with an average time for these price targets to be met of 264.87 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 24-Aug-2020. First documented stock forecast 16-Apr-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$50

5 years 1 months 20 days ago
(24-Aug-2020)

11/11 (100%)

$19.95 (66.39%)

190

Hold

$45

5 years 1 months 21 days ago
(23-Aug-2020)

7/7 (100%)

$20.74 (85.49%)

287

Hold

$47

5 years 1 months 25 days ago
(19-Aug-2020)

5/5 (100%)

$18.45 (64.62%)

320

Hold

$38

5 years 1 months 25 days ago
(19-Aug-2020)

3/3 (100%)

$1.53 (4.20%)

124

Hold

$42

$-10.48 (-19.97%)

$42

5 years 1 months 26 days ago
(18-Aug-2020)

3/4 (75%)

$-10.12 (-19.42%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?

On average it took 264.87 days on average for the stock forecasts to be realized with a an average price target met ratio 96.11

Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?

Danielle Brill works at TRUIST and has 7 price targets and 9 ratings on MNTA

Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?

Robyn Karnauskas with highest potential upside - $4.52

Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?

Dana Flanders with lowest potential downside - -$38.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?